The polypropylene (PP)-like material combines enhanced strength properties with the biocompatibility of medical-grade materials, potentially making it well-suited to producing medical devices. What’s more, the high-impact, durable plastic has also been tested and cleared by the U.S. Food and Drug Administration (FDA) for use within clinical environments. As a result, the polymer could be used for manufacturing products such as orthotics guides and braces, or even to print nasal testing swabs for COVID-19.
“We are thrilled to bring this product to market in collaboration with Nexa3D,” said Ken Kisner, Henkel’s Head of Innovation for 3D printing. “We developed and tested with Nexa3D’s NXE400 3D printer a multitude of approved workflows designed to unleash the full potential of xMED412’s outstanding physical properties and biocompatibility.”